LivaNova PLC (LIVN) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Medical - Devices उद्योग. कंपनी का मुख्यालय है London, United Kingdom. वर्तमान CEO हैं Vladimir A. Makatsaria.
LIVN के पास है IPO तिथि 2015-10-19, 2,900 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Select, बाजार पूंजीकरण $3.56B.
LivaNova PLC is a global medical device company headquartered in London that designs, develops, manufactures, and sells therapeutic solutions across three primary segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment produces heart-lung machines, oxygenators, and perfusion systems for surgical use, while the Neuromodulation segment markets the VNS Therapy System, an implantable device for treating drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea, and is developing the VITARIA System for heart failure treatment. The Advanced Circulatory Support segment provides temporary life support solutions for cardiopulmonary and respiratory support. LivaNova serves hospitals, medical institutions, and healthcare providers worldwide through a network of direct sales representatives and independent distributors, and collaborates with leading organizations such as Verily on clinical research initiatives.
